World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
82
Citations
27117
World Ranking
16024
National Ranking
8062

Overview

Apostolia Maria Tsimberidou is affiliated with The University of Texas MD Anderson Cancer Center in the United States. Their research spans multiple fields with a focus on oncology and molecular biology, supported by extensive publications in medicine and related subfields.

Their recent significant papers include:

  • Review of precision cancer medicine: Evolution of the treatment paradigm, 2020, Cancer Treatment Reviews
  • T-cell receptor-based therapy: an innovative therapeutic approach for solid tumors, 2021, Journal of Hematology & Oncology

Notably, Apostolia Maria Tsimberidou has contributed to research on diverse topics within cancer treatment and molecular mechanisms, with publications evident in fields such as cancer genomics, diagnostics, cancer immunotherapy, and biomarker research. Their work also encompasses lung and colorectal cancer studies, including genetic factors and therapeutic approaches, as well as research focused on CAR-T cell therapy and advanced breast cancer therapies.

Frequent coauthors collaborating with them include:

  • Sarina A. Piha-Paul
  • Funda Meric-Bernstam
  • David S. Hong
  • Siqing Fu
  • Jordi Rodón

Publications by Apostolia Maria Tsimberidou frequently appear in recognized venues such as:

  • Journal of Clinical Oncology
  • Cancer Research
  • Annals of Oncology
  • Regular and Young Investigator Award Abstracts
  • The Oncologist

Their main fields of study emphasize Medicine and Biochemistry, Genetics, and Molecular Biology. More specifically, they publish extensively in the subfields of Oncology, Molecular Biology, Pulmonary and Respiratory Medicine, Cancer Research, and Immunology.

Apostolia Maria Tsimberidou's research centers on key topics including cancer genomics and diagnostics, cancer immunotherapy and biomarkers, lung cancer treatments and mutations, CAR-T cell therapy research, colorectal cancer studies including genetic factors, and therapies targeting advanced breast cancer.

Best Publications

  • Standards and Guidelines for the Interpretation and Reporting of Sequence Variants in Cancer: A Joint Consensus Recommendation of the Association for Molecular Pathology, American Society of Clinical Oncology, and College of American Pathologists

    Marilyn M. Li;Michael Datto;Eric J. Duncavage;Shashikant Kulkarni

  • Circulating Tumor DNA Analysis in Patients With Cancer: American Society of Clinical Oncology and College of American Pathologists Joint Review

    Jason D. Merker;Geoffrey R. Oxnard;Carolyn Compton;Maximilian Diehn

  • Personalized Medicine in a Phase I Clinical Trials Program: The MD Anderson Cancer Center Initiative

    Apostolia M. Tsimberidou;Nancy G. Iskander;David S. Hong;Jennifer J. Wheler

  • PI3K/AKT/mTOR Inhibitors in Patients With Breast and Gynecologic Malignancies Harboring PIK3CA Mutations

    Filip Janku;Jennifer J. Wheler;Shannon N. Westin;Stacy L. Moulder

  • Genomic and transcriptomic profiling expands precision cancer medicine: the WINTHER trial.

    Jordi Rodon;Jean Charles Soria;Raanan Berger;Wilson H. Miller

  • Review of precision cancer medicine: Evolution of the treatment paradigm.

    Apostolia M. Tsimberidou;Elena Fountzilas;Mina Nikanjam;Razelle Kurzrock

  • PIK3CA Mutations in Patients with Advanced Cancers Treated with PI3K/AKT/mTOR Axis Inhibitors

    Filip Janku;Apostolia Maria Tsimberidou;Ignacio Garrido-Laguna;Xuemei Wang

  • Richter syndrome: biology, incidence, and therapeutic strategies.

    Apostolia Maria Tsimberidou;Michael J. Keating

  • Clinical Outcomes and Prognostic Factors in Patients With Richter's Syndrome Treated With Chemotherapy or Chemoimmunotherapy With or Without Stem-Cell Transplantation

    Apostolia Maria Tsimberidou;Susan O'Brien;Issa Khouri;Francis J. Giles

  • Ipilimumab with Stereotactic Ablative Radiation Therapy: Phase I Results and Immunologic Correlates from Peripheral T Cells

    Chad Tang;James W. Welsh;Patricia de Groot;Erminia Massarelli

  • PIK3CA Mutation H1047R Is Associated with Response to PI3K/AKT/mTOR Signaling Pathway Inhibitors in Early-Phase Clinical Trials

    Filip Janku;Jennifer J. Wheler;Aung Naing;Gerald S. Falchook

  • Improvement of Overall and Failure-Free Survival in Stage IV Follicular Lymphoma: 25 Years of Treatment Experience at The University of Texas M.D. Anderson Cancer Center

    Qi Liu;Luis Fayad;Fernando Cabanillas;Fredrick B. Hagemeister

  • Assessing PIK3CA and PTEN in early-phase trials with PI3K/AKT/mTOR inhibitors.

    Filip Janku;David S. Hong;Siqing Fu;Sarina A. Piha-Paul

  • Outcome in patients with nonleukemic granulocytic sarcoma treated with chemotherapy with or without radiotherapy

    Apostolia Maria Tsimberidou;Hagop M Kantarjian;E. Estey;Jorge E Cortes

  • Other Malignancies in Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

    Apostolia-Maria Tsimberidou;Sijin Wen;Peter McLaughlin;Susan O'Brien

  • Cancer Therapy Directed by Comprehensive Genomic Profiling: A Single Center Study

    Jennifer J. Wheler;Filip Janku;Aung Naing;Yali Li

  • PIK3CA mutations frequently coexist with RAS and BRAF mutations in patients with advanced cancers.

    Filip Janku;J. Jack Lee;Apostolia M. Tsimberidou;David S. Hong

  • Antibody-independent isolation of circulating tumor cells by continuous-flow dielectrophoresis.

    Sangjo Shim;Katherine Stemke-Hale;Apostolia Maria Tsimberidou;Jamileh Noshari

  • Phase IB Study of Vemurafenib in Combination with Irinotecan and Cetuximab in Patients with Metastatic Colorectal Cancer with BRAFV600E Mutation.

    David S. Hong;Van K. Morris;Badi El Osta;Alexey V. Sorokin

  • Targeted therapy in cancer

    Apostolia Maria Tsimberidou

Frequent Co-Authors

Filip Janku
Filip Janku The University of Texas MD Anderson Cancer Center
Sarina Anne Piha-Paul
Sarina Anne Piha-Paul The University of Texas MD Anderson Cancer Center
Razelle Kurzrock
Razelle Kurzrock Medical College of Wisconsin
David S. Hong
David S. Hong The University of Texas MD Anderson Cancer Center
Funda Meric-Bernstam
Funda Meric-Bernstam The University of Texas MD Anderson Cancer Center
Kenneth R. Hess
Kenneth R. Hess The University of Texas MD Anderson Cancer Center
Hagop M. Kantarjian
Hagop M. Kantarjian The University of Texas MD Anderson Cancer Center
Michael J. Keating
Michael J. Keating The University of Texas MD Anderson Cancer Center
Rajyalakshmi Luthra
Rajyalakshmi Luthra The University of Texas MD Anderson Cancer Center
Susan O'Brien
Susan O'Brien University of California, Irvine

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring a career in medicine opens up a wealth of opportunities beyond traditional MD programs. Many prospective healthcare professionals look for flexible study paths, including online degrees and alternative routes into the field.

For example, students interested in nursing can check out a nursing school that don't require teas or HESI exams, making entry into nursing programs more accessible.

Those aiming for leadership roles in healthcare may consider a health care administration degree online, which prepares students for crucial management and administrative positions within medical facilities.

Registered Nurses seeking to advance their careers can explore rn to np programs online. These bridge programs allow RNs to earn a master's degree and become Nurse Practitioners without traditional, lengthy coursework.

Additionally, a online nutrition degree can lead to specialized roles in wellness, dietetics, and public health. These diverse pathways offer flexible and rewarding alternatives for anyone passionate about the healthcare sector.

Best Scientists Citing Apostolia Maria Tsimberidou

Trending Scientists

Recently Published Articles